# FDA 483 - Society Hill Reproductive Medicine - April 11, 2024

Source: https://www.globalkeysolutions.net/records/483/society-hill-reproductive-medicine/7a910999-150b-458e-9f76-b5067812bd92

> FDA 483 for Society Hill Reproductive Medicine on April 11, 2024. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Society Hill Reproductive Medicine
- Inspection Date: 2024-04-11
- Product Type: biologics
- Office Name: Philadelphia District Office
- Summary: Society Hill Reproductive Medicine in Philadelphia was inspected regarding its reproductive HCT/P operations. The inspection revealed that HCT/P donors were not properly determined eligible due to the use of an outdated Zika Virus risk assessment list, which omitted relevant countries. This indicates a failure in donor screening procedures and non-compliance with the firm's standard operating procedure.

## Related Officers

- [issuing_officer](https://www.globalkeysolutions.net/people/emily-a-walters/e80b3581-ffba-4244-9030-b6c9496da932)

Company: https://www.globalkeysolutions.net/companies/society-hill-reproductive-medicine/4bf421d3-8f13-4aeb-b2ca-64e1c9062782

Office: https://www.globalkeysolutions.net/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8